Clear ×
Dogwood Therapeutics, Inc. DWTX

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Oct 19, 2026 8-K 4 signals fired
Other
Use Of Proceeds Disclosure Registrant Bears Registration Expenses Ipo Net Proceeds Disclosure Registration Rights Piggyback Provision
Aug 14, 2026 10-Q 22 signals fired · top 15
Other
Goodwill Acquisition Disclosure Ipo Net Proceeds Disclosure Financing Activities Cash Flow Disclosure Net Loss Reported Ipo Or Capital Raising Completion Goodwill Impairment Operating Lease Rent Expense Disclosed Impairment Charge Breakdown Institutional Investment Enrollment Ahead Of Schedule Warrant Valued Black Scholes Stock Option Grant Disclosed
Core
Secondary Endpoint Mentioned Combination Therapy Mentioned Clinical Trial Result
Jun 17, 2026 8-K 5 signals fired
Other
Say On Pay Vote Result Disclosed Auditor Appointment Ratification Adjournment Proposal Voting Requirement Quorum Presence Disclosed Equity Plan Board Approval Conditional On Shareholder Vote
May 15, 2026 10-Q 32 signals fired · top 15
Other
Financing Activities Cash Flow Disclosure Ipo Or Capital Raising Completion Preliminary Purchase Price Allocation Net Loss Reported Operating Lease Rent Expense Disclosed Institutional Investment Lease Rou Incremental Borrowing Rate Disclosure Enrollment Ahead Of Schedule Ipo Net Proceeds Disclosure Depreciation Expense Composition Disclosure Warrant Valued Black Scholes Stock Option Grant Disclosed
Core
Indication Expansion Clinical Trial Result Combination Therapy Mentioned